Melton P M, Riley A L
Department of Psychology, American University, Washington, DC 20016-8062.
Pharmacol Biochem Behav. 1994 May;48(1):275-9. doi: 10.1016/0091-3057(94)90527-4.
Recently, Melton, Kopman, and Riley (20) reported the rapid acquisition of drug discrimination learning using the sulfated form of cholecystokinin (CCK) within the conditioned taste aversion baseline of drug discrimination learning. The present study was designed to explore the receptor mediation of the stimulus properties of CCK within this procedure. Every fourth day, experimental subjects were given CCK-saccharin-LiCl pairings, and on the intervening recovery days, saccharin alone. Once discriminative control was established, doses of the CCK receptor antagonists devazepide (CCK-type A receptor subtype) and L-365,260 (CCK-type B receptor subtype) were administered in combination with the training dose of CCK. Unlike L-365,260 (1-1000 micrograms/kg), devazepide (1 microgram/kg) blocked the CCK stimulus, suggesting that within this design CCK's stimulus properties are mediated by the CCK-type A receptor subtype.
最近,梅尔顿、科普曼和赖利(20)报告称,在药物辨别学习的条件性味觉厌恶基线内,使用硫酸化形式的胆囊收缩素(CCK)能快速获得药物辨别学习。本研究旨在探讨在此过程中CCK刺激特性的受体介导作用。每隔四天,给实验对象进行CCK-糖精-氯化锂配对,在中间的恢复日只给予糖精。一旦建立了辨别性控制,就将CCK受体拮抗剂地伐西匹(CCK-A型受体亚型)和L-365,260(CCK-B型受体亚型)与CCK的训练剂量联合给药。与L-365,260(1 - 1000微克/千克)不同,地伐西匹(1微克/千克)阻断了CCK刺激,这表明在该设计中CCK的刺激特性是由CCK-A型受体亚型介导的。